Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway.
St. Olavs University Hospital, Østmarka, Trondheim, Norway.
Sleep. 2021 Oct 11;44(10). doi: 10.1093/sleep/zsab118.
Digital cognitive behavioral therapy for insomnia (dCBT-I) is an effective treatment for insomnia. However, less is known about mediators of its benefits. The aim of the present study was to test if intraindividual variability in sleep (IIV) was reduced with dCBT-I, and whether any identified reduction was a mediator of dCBT-I on insomnia severity and psychological distress.
In a two-arm randomized controlled trial (RCT), 1720 adults with insomnia (dCBT-I = 867; patient education about sleep = 853) completed the Insomnia Severity Index (ISI), the Hospital Anxiety and Depression Scale (HADS) and sleep diaries, at baseline and 9-week follow-up. Changes in IIV were analyzed using linear mixed modeling followed by mediation analyses of ISI, HADS, and IIV in singular sleep metrics and composite measures (behavioral indices (BI-Z) and sleep disturbance indices (SI-Z)).
dCBT-I was associated with reduced IIV across all singular sleep metrics, with the largest between-group effect sizes observed for sleep onset latency (SOL). Reduced IIV for SOL and wake after sleep onset had the overall greatest singular mediating effect. For composite measures, SI-Z mediated change in ISI (b = -0.74; 95% confidence interval (CI) -1.04 to -0.52; 13.3%) and HADS (b = -0.40; 95% CI -0.73 to -0.18; 29.2%), while BI-Z mediated minor changes.
Reductions in IIV in key sleep metrics mediate significant changes in insomnia severity and especially psychological distress when using dCBT-I. These findings offer important evidence regarding the therapeutic action of dCBT-I and may guide the future development of this intervention.
Name: Overcoming Insomnia: Impact on Sleep, Health and Work of Online CBT-I Registration number: NCT02558647 URL: https://clinicaltrials.gov/ct2/show/NCT02558647?cond=NCT02558647&draw=2&rank=1.
针对失眠的数字化认知行为疗法(dCBT-I)是一种有效的失眠治疗方法。然而,关于其疗效的中介因素,我们知之甚少。本研究旨在检验 dCBT-I 是否能降低个体内睡眠变异性(IIV),以及任何确定的降低是否是 dCBT-I 对失眠严重程度和心理困扰的中介因素。
在一项两臂随机对照试验(RCT)中,1720 名失眠成年人(dCBT-I = 867;睡眠健康教育= 853)在基线和 9 周随访时完成了失眠严重程度指数(ISI)、医院焦虑抑郁量表(HADS)和睡眠日记。使用线性混合模型分析 IIV 的变化,然后对 ISI、HADS 和 IIV 在单一睡眠指标和综合指标(行为指数(BI-Z)和睡眠障碍指数(SI-Z))中的变化进行中介分析。
dCBT-I 与所有单一睡眠指标的 IIV 降低有关,组间效应最大的观察指标为睡眠潜伏期(SOL)。SOL 和睡眠后觉醒的 IIV 降低具有总体最大的单一中介效应。对于综合指标,SI-Z 介导了 ISI 的变化(b = -0.74;95%置信区间(CI)-1.04 至-0.52;13.3%)和 HADS(b = -0.40;95% CI -0.73 至-0.18;29.2%),而 BI-Z 介导了较小的变化。
在使用 dCBT-I 时,关键睡眠指标中的 IIV 降低可介导失眠严重程度和心理困扰的显著变化。这些发现为 dCBT-I 的治疗作用提供了重要证据,并可能为该干预措施的未来发展提供指导。
名称:克服失眠:在线 CBT-I 对睡眠、健康和工作的影响注册编号:NCT02558647 网址:https://clinicaltrials.gov/ct2/show/NCT02558647?cond=NCT02558647&draw=2&rank=1